Trials / Completed
CompletedNCT01040286
The Efficacy and Safety of Flurbiprofen Chip Versus Chlorhexidine Chip (Periochip®) in Therapy of Adult Chronic Periodontitis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Dexcel Pharma Technologies Ltd. · Industry
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to assess efficacy and safety of Flurbiprofen Chip versus Chlorhexidine chip (Periochip®) in therapy of adult chronic periodontitis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Flurbiprofen | 2.0 mg |
| DRUG | Chlorhexidine | 2.5mg |
Timeline
- Start date
- 2009-08-01
- Completion
- 2010-06-01
- First posted
- 2009-12-29
- Last updated
- 2010-07-07
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT01040286. Inclusion in this directory is not an endorsement.